PF-04620110
Drug timelines are a Plus or Pro feature.
7 regulatory and trial events tracked for PF-04620110, covering 2009-07-20 to 2012-11-06. Get the full timeline:
Most recent: Clinical Trial Update: A Multiple Dose Study Of PF-04620110 In Type 2 Diabetes Patients [Phase 1]